We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T Turnover 6.4%
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+695.64%
AUM
$184B
AUM Growth
-$4.57B
Cap. Flow
-$8.49B
Cap. Flow %
-4.62%
Top 10 Hldgs %
15.06%
Holding
4,187
New
96
Increased
2,386
Reduced
984
Closed
127
Avg Time Held
2.5 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
2.2 years

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$216M
2
CHTR icon
Charter Communications
CHTR
+$192M
3
SLB icon
SLB Ltd
SLB
+$79.3M
4
IBM icon
IBM
IBM
+$70.2M
5
NWL icon
Newell Brands
NWL
+$67.5M

Sector Composition

Rank Sector Weight
1 Healthcare 14.87%
2 Technology 14.38%
3 Financials 13.98%
4 Industrials 10.32%
5 Consumer Discretionary 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AUDC icon
3776
AudioCodes
AUDC
$269M
$77K ﹤0.01%
18,588
– –
2015 Q1
5 quarters
CARM icon
3777
DELISTED
Carisma Therapeutics
CARM
$77K ﹤0.01%
2,332
– –
2014 Q1
9 quarters
GROW icon
3778
US Global Investors
GROW
$33.5M
$76K ﹤0.01%
45,139
– –
2013 Q2
12 quarters
PTN icon
3779
Palatin Technologies
PTN
$10.8M
$76K ﹤0.01%
138
– –
2014 Q1
9 quarters
REED icon
3780
DELISTED
Reeds, Inc. Common Stock
REED
$76K ﹤0.01%
621
– –
2013 Q2
12 quarters
NTBL icon
3781
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$75K ﹤0.01%
+471
New +$60.9K
2016 Q2
0 quarters
IEC
3782
DELISTED
IEC Electronics Corp.
IEC
$75K ﹤0.01%
18,187
– –
2013 Q2
12 quarters
CETX icon
3783
Cemtrex
CETX
$2.94M
– –
0
– –
2015 Q3
3 quarters
FLNT icon
3784
Fluent
FLNT
$86.3M
$74K ﹤0.01%
+2,635
New +$80.2K
2016 Q2
0 quarters
GVP icon
3785
DELISTED
GSE Systems, Inc.
GVP
$74K ﹤0.01%
3,354
– –
2013 Q2
12 quarters
RHE
3786
DELISTED
Regional Health Properties, Inc.
RHE
$74K ﹤0.01%
3,380
– –
2013 Q2
12 quarters
ARCW
3787
DELISTED
ARC Group Worldwide, Inc
ARCW
$74K ﹤0.01%
32,485
– –
2014 Q4
6 quarters
LEU icon
3788
Centrus Energy
LEU
$2.33B
$72K ﹤0.01%
22,164
– –
2015 Q1
5 quarters
ENG icon
3789
DELISTED
ENGlobal Corp
ENG
$72K ﹤0.01%
7,526
– –
2013 Q2
12 quarters
KUST
3790
Kustom Entertainment Inc
KUST
$2.46M
– –
0
– –
2015 Q2
4 quarters
ELMD icon
3791
Electromed
ELMD
$228M
$71K ﹤0.01%
18,483
– –
2014 Q4
6 quarters
BGMS icon
3792
Bio Green Med Solution Inc
BGMS
$5.96M
– –
0
– –
2013 Q2
12 quarters
MRNS icon
3793
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$70K ﹤0.01%
13,904
+923
+7% +$17K
2015 Q1
5 quarters
DVD
3794
DELISTED
Dover Motorsports
DVD
$70K ﹤0.01%
32,679
– –
2013 Q2
12 quarters
ELON
3795
DELISTED
Echelon Corp
ELON
$70K ﹤0.01%
14,804
– –
2013 Q2
12 quarters
COSI
3796
DELISTED
COSI INC NEW COM STK (DE)
COSI
$70K ﹤0.01%
140,312
– –
2013 Q2
12 quarters
SGMA icon
3797
DELISTED
Sigmatron International
SGMA
$69K ﹤0.01%
11,463
– –
2014 Q1
9 quarters
IRG
3798
DELISTED
Ignite Restaurant Group, Inc.
IRG
$69K ﹤0.01%
44,783
– –
2013 Q2
12 quarters
MEMP
3799
DELISTED
Memorial Production Partners LP Common Units
MEMP
$69K ﹤0.01%
36,382
– –
2013 Q4
10 quarters
ECTE
3800
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$68K ﹤0.01%
52,333
– –
2013 Q2
12 quarters

Similar funds

Geode Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Geode Capital Management held 4,187 positions worth $184B, down 2.4% from $188B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Geode Capital Management withdrew a net $8.49B in Q2 2016, closing 127 positions and reducing 984 holdings. Its most notable exit was Affymetrix Inc, an estimated $7.53B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

Against the trend, Geode Capital Management opened a new position in S&P Global worth $215M.

  • Geode Capital Management's largest Q2 2016 buy was S&P Global: 2,009,728 shares worth $215M.
  • Geode Capital Management added most to Charter Communications in Q2 2016, an estimated $192M increase.
  • Geode Capital Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $72.2M.
  • Geode Capital Management fully exited Affymetrix Inc in Q2 2016, selling an estimated $7.53B.
  • Geode Capital Management's ten largest holdings make up 15% of its $184B portfolio in Q2 2016.
  • Geode Capital Management opened 96 new positions and closed 127 in Q2 2016.
  • Geode Capital Management's portfolio value fell 2.4% quarter-over-quarter to $184B.

Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.